Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 14, 2023 07:30 ET | Source: Titan Medical Inc.

Titan Medical Announces Executive Leadership Updates and Receipt of Nasdaq Notification Regarding Audit Committee Requirements

Toronto, Ontario, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (the “Company” or “Titan”) (Nasdaq: TMDI; TSX: TMD) today announced senior leadership changes and the receipt of a notification...
February 08, 2023 09:15 ET | Source: Titan Medical Inc.

Titan Medical Provides Corporate Update

TORONTO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (the “Company” or “Titan”) (Nasdaq: TMDI; TSX: TMD) today provided an update on the previously announced review and evaluation of...
January 10, 2023 16:08 ET | Source: Baum Hedlund Aristei & Goldman

Baum Hedlund Aristei & Goldman is Now Wisner Baum

Los Angeles, California, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Baum Hedlund Aristei & Goldman, PC has changed its name to Wisner Baum, LLP. The announcement comes as the award-winning plaintiffs...
January 09, 2023 07:30 ET | Source: Titan Medical Inc.

Titan Medical Shares Latest Technology Innovation and Announces Meeting Participation During J.P. Morgan Healthcare Conference Week

TORONTO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies...
December 28, 2022 17:01 ET | Source: Titan Medical Inc.

Titan Medical Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing

TORONTO, ON, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD) (the “Company”), a medical device company focused on the development and commercialization of innovative...
December 15, 2022 07:00 ET | Source: Titan Pharmaceuticals, Inc.

Titan Pharmaceuticals Provides Shareholder Update

Signs Non-Binding Letter of Intent for Transformational TransactionContinues to Make Substantial Progress on Strategic Transactions Including Sale of Existing Assets SAN FRANCISCO, Dec. 15, 2022 ...
December 13, 2022 07:30 ET | Source: Titan Medical Inc.

Titan Medical Granted Patent Covering User Experience, Further Enhancing its Intellectual Property in Robotic Assisted Surgery

TORONTO, ON, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical...
December 12, 2022 07:49 ET | Source: Titan Pharmaceuticals, Inc.

UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.

SAN FRANCISCO, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has granted an exclusive license to Ocular Therapeutix...
December 12, 2022 06:30 ET | Source: Titan Pharmaceuticals, Inc.

Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.

SAN FRANCISCO, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has granted an exclusive license to Ocular Therapeutix...
December 07, 2022 07:30 ET | Source: Titan Medical Inc.

Titan Medical Suspends Special Meeting of Shareholders in Conjunction with Initiation of Strategic Review Process

TORONTO, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS), today announced that in...